Copertina

Assessing the Operational Characteristics of the Individual Causal Association as a Metric of Surrogacy in the Binary Continuous Setting

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fenny Ong, Geert Molenberghs, Andrea Callegaro, Wim Van der Elst, Florian Stijven, Geert Verbeke, Ingrid Van Keilegom, Ariel Alonso
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pharmaceutical Statistics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation
di: Ariel Alonso Abad, et al.
Pubblicazione: (2024)

A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints
di: Dries De Witte, et al.
Pubblicazione: (2025)

Handling Missing Data in Participants with Baseline but No Post‐Baseline Data
di: Craig Mallinckrodt, et al.
Pubblicazione: (2026)

Application of Causal Inference to Establish Assay Effect in the Absence of a Bridging Study: A Case Study of MenACWY ‐ CRM Conjugate Vaccine Data
di: Meike Adani, et al.
Pubblicazione: (2026)

Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials
di: Andrea Callegaro, et al.
Pubblicazione: (2024)

Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting
di: Hui Quan, et al.
Pubblicazione: (2024)

Phase III Probability of Success When Early Development Is Based on a Putative Surrogate Endpoint: A Vaccine Efficacy Case Study
di: Andrea Callegaro, et al.
Pubblicazione: (2026)

بیوتکنولوژی دارویی | اصول و کاربردها
di: Qalavand, Mostafa
Pubblicazione: (2025)

Global Pharmaceutical Container Market 2025 To 2034
di: Sirsat, Nitin
Pubblicazione: (2025)

The Estimand Framework and Causal Inference: Complementary Not Competing Paradigms
di: Thomas Drury, et al.
Pubblicazione: (2025)

Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved
di: Jia Wang, et al.
Pubblicazione: (2024)

Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian Copula
di: Federico Bonofiglio
Pubblicazione: (2024)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
di: Dan Jackson, et al.
Pubblicazione: (2024)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
di: Konstantinos Sechidis, et al.
Pubblicazione: (2024)

Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy
di: Sunita Rehal, et al.
Pubblicazione: (2026)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
di: Heng Li, et al.
Pubblicazione: (2025)

A case study: Assessing the efficacy of the revised dosage regimen via prediction model for recurrent event rate using biomarker data
di: Ahrim Youn, et al.
Pubblicazione: (2024)

Global Sustainable Pharmaceutical Packaging Market 2025 To 2034
di: Sirsat, Nitin
Pubblicazione: (2025)

A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example
di: Christophe Dessart, et al.
Pubblicazione: (2024)

A Reflection on the Impact of Misspecifying Unidentifiable Causal Inference Models in Surrogate Endpoint Evaluation
di: Deliorman, Gokce, et al.
Pubblicazione: (2024)

Pharmaceutical care practice in patients with chronic kidney disease
di: Dadier Antonio Arroyo Monterroza
Pubblicazione: (2017)

Novel Pharmaceuticals from Kenyan Marine Cyanobacteria.
di: Dzeha, T.
Pubblicazione: (2004)

Global Blister Packaging Machine Pharmaceutical Market 2025 To 2034
di: Sirsat, Nitin
Pubblicazione: (2025)

Impact of Methods of Preparation on Mechanical Properties, Dissolution Behavior, and Tableting Characteristics of Ibuprofen-Loaded Amorphous Solid Dispersions
di: Ajam Uddin, et al.
Pubblicazione: (2024)

Cellulose- and Saccharide-Based Orally Dispersible Thin Films Transform the Solid States and Dissolution Characteristics of Poorly Soluble Curcumin
di: Helmy Yusuf, et al.
Pubblicazione: (2024)

Frailty model with change points for survival analysis
di: Masahiro Kojima, et al.
Pubblicazione: (2024)

Time‐to‐event estimands and loss to follow‐up in oncology in light of the estimands guidance
di: Jonathan M. Siegel, et al.
Pubblicazione: (2024)

Simulation‐based sample size calculations of marginal proportional means models for recurrent events with competing risks
di: Julie Funch Furberg, et al.
Pubblicazione: (2024)

Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application
di: Sören Budig, et al.
Pubblicazione: (2026)

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events
di: Minghong Yao, et al.
Pubblicazione: (2024)

Predictive Ppk calculations for biologics and vaccines using a Bayesian approach – a tutorial
di: Jos Weusten, et al.
Pubblicazione: (2024)

Principles for Defining Estimands in Clinical Trials—A Proposal
di: Tobias Mütze, et al.
Pubblicazione: (2024)

Quality by Design for Preclinical In Vitro Assay Development
di: Jonathan Jones, et al.
Pubblicazione: (2024)

Applying the Estimand Framework to Non‐Inferiority Trials
di: Helle Lynggaard, et al.
Pubblicazione: (2024)

Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
di: David Hinds, et al.
Pubblicazione: (2026)

Current developments of the estimand concept
di: Alexander Fierenz, et al.
Pubblicazione: (2024)

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )
di: Paul Faya, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)

Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
di: Xiaolong Luo, et al.
Pubblicazione: (2025)

Comparative Analyses of Bioequivalence Assessment Methods for In Vitro Permeation Test Data
di: Sami Leon, et al.
Pubblicazione: (2024)